(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 16.91% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.18%.
Radnet's revenue in 2026 is $2,040,210,000.On average, 11 Wall Street analysts forecast RDNT's revenue for 2026 to be $194,418,373,125, with the lowest RDNT revenue forecast at $184,561,633,250, and the highest RDNT revenue forecast at $204,896,010,000. On average, 10 Wall Street analysts forecast RDNT's revenue for 2027 to be $215,218,422,625, with the lowest RDNT revenue forecast at $195,815,391,375, and the highest RDNT revenue forecast at $233,612,496,250.
In 2028, RDNT is forecast to generate $240,131,914,750 in revenue, with the lowest revenue forecast at $228,257,259,625 and the highest revenue forecast at $249,445,369,750.